Holen Sie sich die Stockscreener-App
427.05
0.34%
1.45
Handel nachbörslich:
423.00
-4.05
-0.95%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MDGL?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$425.60
Offen:
$425.41
24-Stunden-Volumen:
243.39K
Relative Volume:
0.65
Marktkapitalisierung:
$9.48B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-518.67M
KGV:
-17.00
EPS:
-25.12
Netto-Cashflow:
$-438.32M
1W Leistung:
-4.83%
1M Leistung:
+15.47%
6M Leistung:
+22.59%
1J Leistung:
+82.98%
1-Tages-Spanne:
$422.92
$428.28
1-Wochen-Bereich:
$418.36
$450.23
52-Wochen-Spanne:
$200.63
$457.16
Madrigal Pharmaceuticals Inc Stock (MDGL) Company Profile
Firmenname
Madrigal Pharmaceuticals Inc
Sektor
Branche
Telefon
404-380-9263
Adresse
200 BARR HARBOR DRIVE, SUITE 400, WEST CONSHOHOCKEN, PA
Vergleichen Sie MDGL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDGL
Madrigal Pharmaceuticals Inc
|
427.05 | 9.49B | 0 | -518.67M | -438.32M | -25.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.36 | 100.82B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.24 | 60.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.06 | 60.69B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
752.32 | 46.32B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
327.20 | 36.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Madrigal Pharmaceuticals Inc Stock (MDGL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-04 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-02-28 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2025-02-27 | Bestätigt | H.C. Wainwright | Buy |
| 2024-06-28 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2024-06-11 | Eingeleitet | Wolfe Research | Outperform |
| 2024-04-22 | Eingeleitet | BofA Securities | Underperform |
| 2024-03-15 | Hochstufung | B. Riley Securities | Sell → Neutral |
| 2024-03-06 | Eingeleitet | Citigroup | Buy |
| 2024-02-26 | Herabstufung | B. Riley Securities | Neutral → Sell |
| 2022-12-20 | Bestätigt | Oppenheimer | Outperform |
| 2022-12-19 | Bestätigt | H.C. Wainwright | Buy |
| 2022-12-19 | Bestätigt | Piper Sandler | Overweight |
| 2022-12-19 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2022-07-08 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2021-10-07 | Eingeleitet | Jefferies | Buy |
| 2021-08-06 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2021-05-20 | Fortgesetzt | Goldman | Buy |
| 2020-11-24 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-11-06 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-31 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-05 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2020-05-05 | Eingeleitet | Chardan Capital Markets | Buy |
| 2020-01-30 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-01-09 | Hochstufung | UBS | Neutral → Buy |
| 2019-11-07 | Bestätigt | H.C. Wainwright | Buy |
| 2019-06-25 | Eingeleitet | Stifel | Hold |
| 2019-06-10 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2019-02-28 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-22 | Eingeleitet | SVB Leerink | Outperform |
| 2019-01-23 | Eingeleitet | UBS | Neutral |
| 2018-12-14 | Eingeleitet | Wolfe Research | Outperform |
| 2018-12-12 | Eingeleitet | B. Riley FBR | Neutral |
| 2018-11-19 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2018-11-16 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-09-04 | Eingeleitet | Citigroup | Buy |
| 2018-08-06 | Herabstufung | Goldman | Buy → Neutral |
| 2018-06-28 | Eingeleitet | Raymond James | Mkt Perform |
Alle ansehen
Madrigal Pharmaceuticals Inc Aktie (MDGL) Neueste Nachrichten
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Market Overview: Can Madrigal Pharmaceuticals Inc weather a recession2025 Volume Leaders & Safe Capital Growth Stock Tips - خودرو بانک
Intech Investment Management LLC Has $3.24 Million Position in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Madrigal (MDGL) Secures $500M to Fuel MASH Pipeline Expansion - MSN
Growth Value: Will Madrigal Pharmaceuticals Inc outperform during market ralliesJuly 2025 Big Picture & Fast Gaining Stock Strategy Reports - خودرو بانک
Market Review: What are Madrigal Pharmaceuticals Incs earnings expectationsEarnings Growth Summary & Weekly High Conviction Trade Ideas - خودرو بانک
EP Wealth Advisors LLC Invests $200,000 in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Pullback Watch: Is Madrigal Pharmaceuticals Inc stock good for income investors2025 Technical Patterns & Daily Growth Stock Tips - خودرو بانک
Rhumbline Advisers Acquires 1,924 Shares of Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Madrigal stock jumps 13% after Rezdiffra Q3 sales beat estimates - MSN
Gains Report: Is Madrigal Pharmaceuticals Inc in a long term uptrend2025 Bull vs Bear & Weekly Momentum Stock Picks - خودرو بانک
Aug PostEarnings: Is Madrigal Pharmaceuticals Inc stock forming a cup and handleLayoff News & Technical Buy Zone Confirmation - خودرو بانک
Short Squeeze: How is Capital City Bank Group Inc. managing supply chain issuesPortfolio Risk Report & Daily Stock Momentum Reports - خودرو بانک
Recap Report: Does Madrigal Pharmaceuticals Inc. stock benefit from AI growthJuly 2025 Patterns & Weekly Consistent Profit Watchlists - خودرو بانک
Woodline Partners LP Raises Holdings in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Madrigal Pharmaceuticals (NASDAQ:MDGL) CEO Sells $3,243,740.77 in Stock - MarketBeat
Assessing Madrigal Pharmaceuticals (MDGL) Valuation After Rezdiffra’s Strong Q2 Sales and EU Approval - Sahm
Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target Raised to $526.00 at Canaccord Genuity Group - MarketBeat
Canaccord Genuity Group Forecasts Strong Price Appreciation for Madrigal Pharmaceuticals (NASDAQ:MDGL) Stock - Defense World
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Madrigal Pharmaceuticals stock price target raised by Canaccord on MASH drug outlook - Investing.com Canada
Madrigal Pharmaceuticals (NASDAQ:MDGL) Reaches New 12-Month HighTime to Buy? - MarketBeat
What is HC Wainwright's Estimate for MDGL Q3 Earnings? - MarketBeat
Canaccord Genuity Boosts Madrigal Pharmaceuticals (MDGL) Price T - GuruFocus
Don't Ignore The Insider Selling In Madrigal Pharmaceuticals - simplywall.st
Cinctive Capital Management LP Sells 4,315 Shares of Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
CoreWeave and Madrigal’s Insider Trades Flash Bullish Signals - Investing.com
CoreWeave and Madrigal's Insider Trades Flash Bullish Signals - MarketBeat
Madrigal Pharmaceuticals Grants Equity Awards to New Employees - MSN
Madrigal Pharma CEO Sibold sells $3.24 million in stock By Investing.com - Investing.com Canada
Madrigal Pharma CEO Sibold sells $3.24 million in stock - Investing.com
Madrigal Pharmaceuticals (NASDAQ:MDGL) Now Covered by Analysts at HC Wainwright - MarketBeat
Can Madrigal Pharmaceuticals Inc. stock double in the next yearQuarterly Performance Summary & Free Expert Verified Stock Movement Alerts - Lancaster City Council
Can Madrigal Pharmaceuticals Inc. benefit from deglobalizationPortfolio Value Report & Short-Term High Return Ideas - Lancaster City Council
A Fresh Look at Madrigal Pharmaceuticals (MDGL) Valuation Following Recent Share Price Momentum - Yahoo Finance
Cutter Capital Management LP Invests $7.95 Million in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
Madrigal Pharmaceuticals stock hits all-time high at 443.86 USD By Investing.com - Investing.com Canada
Published on: 2025-09-08 23:49:37 - beatles.ru
Madrigal Pharmaceuticals stock hits all-time high at 443.86 USD - Investing.com
Madrigal Pharmaceuticals to Present at Morgan Stanley Global Health Care Conference - MSN
Madrigal Pharmaceuticals Inc. Facing Inflection Point in Trend AnalysisWeekly Trade Report & Free Technical Confirmation Trade Alerts - beatles.ru
ADAR1 Capital Management LLC Makes New Investment in Madrigal Pharmaceuticals, Inc. $MDGL - MarketBeat
48,690 Shares in Madrigal Pharmaceuticals, Inc. $MDGL Purchased by Braidwell LP - MarketBeat
Madrigal Pharmaceuticals (NASDAQ:MDGL) Reaches New 52-Week HighTime to Buy? - MarketBeat
What is the PEG ratio of Madrigal Pharmaceuticals Inc.July 2025 Chart Watch & High Yield Stock Recommendations - خودرو بانک
Does Madrigal Pharmaceuticals Inc. have consistent dividend growthTrade Signal Summary & Risk Controlled Stock Alerts - خودرو بانک
Is Madrigal Pharmaceuticals Inc. a top pick in the sectorEarnings Performance Report & Accurate Technical Buy Alerts - خودرو بانک
What is the target price for Madrigal Pharmaceuticals Inc. stockWeekly Profit Report & AI Enhanced Execution Alerts - خودرو بانک
Finanzdaten der Madrigal Pharmaceuticals Inc-Aktie (MDGL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.77%
1.53%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):